Latest information


Provigate received PCA grant from NEDO.

Development of an IoT home blood glucose monitoring system

Provigate’s proposal was selected by the New Energy and Industrial Technology Development Organisation (commonly known as NEDO) under its ‘Research and Development Venture Support Project/Product Commercialisation Alliance’ (commonly known as NEDO-PCA).
In this proposed project, a prototype system will be developed by combining the elemental technologies of the blood sample measurement system developed under the support of the NEDO-SCA project with the unique diabetes-related biomarker whose usefulness was confirmed in the AMED Advanced Measurement Project. This project will be carried out in conjunction with the business and capital alliance with Daikin Industries.
The project period is scheduled from the grant decision date to 28 February 2021.

People may think of glucose monitoring as simple as this: "Diabetes is a disease of blood sugar. This is why people with diabetes use glucometer."
However, it's not that simple. Blood sugar measurement has diverse objectives, including diagnosing diabetes, dosing self-injection of insulin, avoiding hypoglycemia due to excessive drug efficacy, and behavior change.
You must choose the appropriate blood sugar measurement method for your purpose.

There are two types of self-blood glucose measurement methods: SMBG (Self-Monitoring of Blood Glucose), which is widely used, and CGM (Continuous Glucose Monitoring), which has become popular in recent years.
These two blood glucose measurement methods are designed mainly for patients who self-inject insulin and other injectable drugs.
Until now, there has been no simple and daily method for measuring blood glucose at home other than these two methods.

Some drugs, such as insulin, are very potent and can cause dangerous hypoglycemia if the dosage is incorrect.
Therefore, for example, those who use insulin must measure their blood glucose accurately before self-injection at home and carefully determine the dose.
After injection, if there are signs of hypoglycemia, it is necessary to measure blood glucose immediately. If necessary, you need to take some sugar to avoid hypoglycemia.
However, both methods have an issue with invasiveness. In addition, they cost a lot. CGM costs at least $60 and needs to be replaced every two weeks, which is also a significant economic burden. SMBG requires frequent measurements, so the total cost becomes significant when accumulated.
Unfortunately, SMBG and CGM are not suitable for everyone due to invasiveness and cost.



Let’s make significant innovations in the era of the healthcare revolution.
We’re looking for talented and enthusiastic individuals to create a better future for everyone.


Feel free to contact us about our services, recruitment and interviews.

Copyright© Provigate, Inc. All Rights Reserved.